Free Trial
David Windley

David Windley Analyst Performance

Managing Director at Jefferies Financial Group

David Windley is a stock analyst at Jefferies Financial Group focused in the medical sector, covering 19 publicly traded companies. Over the past year, David Windley has issued 27 stock ratings, including buy and hold recommendations. While full access to David Windley's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Windley's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
67 Last 11 Years
Buy Recommendations
76.12% 51 Buy Ratings
Companies Covered
19 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy76.1%51 ratings
Hold23.9%16 ratings
Sell0.0%0 ratings

Out of 67 total stock ratings issued by David Windley at Jefferies Financial Group, the majority (76.1%) have been Buy recommendations, followed by 23.9% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
73.7% of companies on NYSE
14 companies
NASDAQ
21.1% of companies on NASDAQ
4 companies
OTCMKTS
5.3% of companies on OTCMKTS
1 company

David Windley, an analyst at Jefferies Financial Group, currently covers 19 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
14 companies
73.7%
Finance
2 companies
10.5%
Consumer Staples
1 company
5.3%
Business Services
1 company
5.3%
Miscellaneous
1 company
5.3%

David Windley of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on Finance and Consumer Staples companies.

Coverage Industries

IndustryPercentage
MED - HMO
5 companies
26.3%
MEDICAL SERVICES
4 companies
21.1%
INS - MULTI LINE
2 companies
10.5%
MED INSTRUMENTS
2 companies
10.5%
MED/DENTAL - SUPP
1 company
5.3%
BEVERAGES - ALCOH
1 company
5.3%
MEDICAL INFO SYS
1 company
5.3%
MED - BIOMED/GENE
1 company
5.3%
COMPUTER INTEGRATED SYSTEMS DESIGN
1 company
5.3%
HOLDING & OTHER INVESTMENT OFFICES
1 company
5.3%

David Windley's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Centene Corporation stock logo
CNC
Centene
4/29/2026Boost Price Target$49.42$48.00Hold
Elevance Health, Inc. stock logo
ELV
Elevance Health
4/20/2026Lower Price Target$323.02$391.00Buy
Cigna Group stock logo
CI
Cigna Group
4/20/2026Lower Price Target$278.29$330.00Buy
Centene Corporation stock logo
CNC
Centene
4/20/2026Reiterated Rating$38.11$39.00Hold
Oscar Health, Inc. stock logo
OSCR
Oscar Health
4/20/2026Upgrade$15.78$16.00Hold
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4/20/2026Boost Price Target$323.62$373.00Buy
Icon Plc stock logo
ICLR
Icon
2/23/2026Set Price Target$99.70$135.00Buy
Icon Plc stock logo
ICLR
Icon
2/23/2026Upgrade$104.66$135.00Buy
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2/13/2026Upgrade$416.04$560.00Buy
Humana Inc. stock logo
HUM
Humana
2/12/2026Lower Price Target$180.49$235.00Buy
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2/10/2026Reiterated Rating$250.33$295.00Buy
Cigna Group stock logo
CI
Cigna Group
2/9/2026Boost Price Target$294.00$333.00Buy
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2/6/2026Lower Price Target$187.48$255.00Buy
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
1/28/2026Lower Price Target$294.00$340.00Buy
Humana Inc. stock logo
HUM
Humana
1/26/2026Lower Price Target$196.00$310.00Buy
Humana Inc. stock logo
HUM
Humana
12/5/2025Upgrade$252.84$313.00Buy
Diageo plc stock logo
DEO
Diageo
12/3/2025Reiterated Rating$92.03Neutral
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
11/24/2025Reiterated Rating$243.98$330.00Buy
Cigna Group stock logo
CI
Cigna Group
11/3/2025Reiterated Rating$244.67$310.00Buy
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
10/17/2025Boost Price Target$357.39$409.00Buy
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
9/9/2025Upgrade$161.97$195.00Buy
IQVIA Holdings Inc. stock logo
IQV
IQVIA
9/9/2025Upgrade$187.72$225.00Buy
Icon Plc stock logo
ICLR
Icon
9/9/2025Downgrade$177.81$175.00Hold
Medpace Holdings, Inc. stock logo
MEDP
Medpace
9/9/2025Boost Price Target$492.09$450.00Hold
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
9/9/2025Boost Price Target$10.32$9.50Hold
STERIS plc stock logo
STE
STERIS
5/29/2025Initiated Coverage$245.03$263.00Hold
SelectQuote, Inc. stock logo
SLQT
SelectQuote
5/21/2025Initiated Coverage$2.26$2.75Hold
Centene Corporation stock logo
CNC
Centene
4/29/2025Lower Price Target$59.23$61.00Hold
Centene Corporation stock logo
CNC
Centene
4/8/2025Upgrade$61.27$64.00Hold